ASHLEE ROBBINS: Open Payments
NPI 1497465066 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,199 in 109 payments from 14 companies in 2025. Trend: 2023 $1,033 · 2024 $1,594 · 2025 $2,199
Food & beverage: $2,199
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $347 |
| Enterra Medical, Inc. | 2 | $340 |
| Janssen Biotech, Inc. | 16 | $274 |
| GENZYME CORPORATION | 11 | $247 |
| Madrigal Pharmaceuticals | 13 | $246 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $208 |
| Aimmune Therapeutics, Inc. | 11 | $184 |
| Ardelyx, Inc. | 4 | $102 |
| QOL Medical, LLC | 3 | $73 |
| Lilly USA, LLC | 4 | $62 |
Products named: DUPIXENT, TREMFYA, REZDIFFRA, ENTYVIO, ZENPEP, RINVOQ, IBSRELA, CREON.
Industry payments across MS — which companies pay providers there.
